Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,298,501 papers from all fields of science
Search
Sign In
Create Free Account
Thalidomide 150 MG Oral Capsule [Thalomid]
Known as:
Thalomid 150 MG Oral Capsule
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Magnesium stearate
Oral Capsule
Thalidomide
Thalomid
Expand
Broader (1)
Thalidomide 150 MG Oral Capsule
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Updated Report of T-Bird (thalidomide, clarithromycin/[Biaxin®], lenalidomide/[Revlimid®], Dexamethasone) Therapy for Upfront Use In Symptomatic Multiple Myeloma
T. Mark
,
J. O'Loughlin
,
+9 authors
R. Niesvizky
2010
Corpus ID: 78465000
Abstract 3050 Background: We hypothesized that the addition of thalidomide to BiRD therapy (clarithromycin/[Biaxin…
Expand
2009
2009
Multiple Myeloma: Patient out-of-Pocket Costs and Health Care Utilization.
B. Pinsky
,
Hui Huang
,
A. Teitelbaum
,
D. Esseltine
,
H. Henk
2009
Corpus ID: 208392314
Abstract Abstract 1366 Poster Board I-388 Background: Multiple myeloma (MM) is a complex disease that places a significant burden…
Expand
2008
2008
Thalidomide, lenalidomide and pomalidomide reduce the metastatic capability of cancer cells in vivo and in vitro
Wai M. Liu
,
J. Henry
,
+4 authors
C. Galustian
2008
Corpus ID: 202822912
1173 Thalidomide (Thalomid®), lenalidomide (Revlimid®, CC-5013) and pomalidomide (CC-4047), display immunomodulatory, anti…
Expand
2006
2006
Response to “Acute Tumor Lysis Syndrome After Thalidomide Therapy in Advanced Hepatocellular Carcinoma”
A. Zhu
2006
Corpus ID: 73242967
I read with great interest the report by Lee and colleagues, illustrating the development of tumor lysis syndrome (TLS) following…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE